Experts warn FDA Twitter guidance will silence social conversation

Having had a week to mull over the FDA's latest batch of social media guidance, some observers have concluded the agency is making a blunt statement to brand managers: Don't use Twitter. A SVP at Digitas Health reached the conclusion after looking into how much of Twitter's ($TWTR) 140-character limit would be taken up by listing the risks of a drug. FiercePharmaMarketing story

Suggested Articles

Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.

Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.

Medisafe has started pitching an app and services to increase medication adherence and facilitate patient recruitment to biopharma companies.